FXN and Friedreich ataxia: We demonstrate that administration of G-CSF to people with FA is safe and tolerable, leads to effective haematopoietic stem cell (HSC) mobilisation and improves the biochemical profile of molecules relevant to the pathogenesis of FA including increasing frataxin levels.